SCTL Societal CDMO, Inc.

Societal CDMO Inc, formerly Recro Pharma Inc is a contract development and manufacturing company. The company is engaged in the development, formulation, regulatory support, manufacturing, and packaging of oral solid dose drug products. Its product portfolio includes Ritalin LA, Focalin XR, Verelan PM, SR & Verapamil PM, Verapamil SR, and Zohydro ER.

As of 07/01/2022     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Drug Manufacturers—Specialty &
Index country:  USA
Country of incorporation:  
IPO date:  03/07/2014
Outstanding shares:  56,632,541
Average volume:  250,279
Market cap:   $43,035,068
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Valuation   (See tab for details)
PE ratio:   -5.07
PB ratio:   1.15
PS ratio:   0.54
Return on equity:   -22.66%
Net income %:   -11.13%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy